Atlas Trials

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Clinical trial NCT00908778 · UNKNOWN

Trial details

NCT number
NCT00908778
Sponsor
Vitreoretinal Technologies, Inc.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic Retinopathy
Start date
2008-10-01
Primary completion
2010-07-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.